The Heart & Vascular Center of Arizona is now able to treat your Aortic Aneurysm Patients with the new Trivascular Ovation Prime Endograft.

The advantages of the Trivascular Ovation Prime Endograft include Unparalleled Clinical Data, Novel Technology, Percutaneous Procedure/No Incisions Necessary, Next Day Discharge, Early Ambulation (2-4 hours), Conscious Sedation and Custom Seal.

200,000 People are diagnosed with an Abdominal Aortic Aneurysm each year, accounting for 15,000 deaths annually and is the third leading cause of death for men over the age of 60.